DKS Co Ltd 2021 IR
The report highlights DKS Co. Ltd.'s financial and sustainability performance for fiscal 2020, marking the second year of its medium-term management plan "FELIZ 115." The company achieved net sales of 59,140 million yen and operating income of 4,485 million yen, driven by strong growth in electronic device materials despite COVID-19 challenges. Key achievements include the discovery of "Naturido," a novel component from medical fungus shown to improve brain function, and the selection of DKS as a "Health & Productivity Stock" for the second consecutive year. Additionally, the company launched a Green Transformation (GX) planning team to formulate long-term strategies toward carbon neutrality by 2050.
Company: DKS Co Ltd
Sector: Materials
Country: Japan
Year: 2021
Type: IR
Pages: 74
DKS Co Ltd
Corporate Report
The report highlights DKS Co. Ltd.'s financial and sustainability performance for fiscal 2020, marking the second year of its medium-term management plan "FELIZ 115." The company achieved net sales of 59,140 million yen and operating income of 4,485 million yen, driven by strong growth in electronic device materials despite COVID-19 challenges. Key achievements include the discovery of "Naturido," a novel component from medical fungus shown to improve brain function, and the selection of DKS as a "Health & Productivity Stock" for the second consecutive year. Additionally, the company launched a Green Transformation (GX) planning team to formulate long-term strategies toward carbon neutrality by 2050.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Apr 1, 2020 - Mar 31, 2021
Fiscal Year
2020
Published
Dec 1, 2021
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Energy Consumption
Total Waste
Women in Management
Net Zero Target
Employees